Opinion | DeSantis, RFK Jr. and What Made Florida Great
[ad_1] What to Read Next [ad_2] Source link
life sciences
Read More
CVS to Shed 5,000 Jobs in Cost-Cutting Push
[ad_1] The healthcare giant wants to trim corporate roles and spending on travel and its use of consultants. [ad_2] Source…
Health Care Roundup: Market Talk
[ad_1] GE HealthCare, Ergomed and more in the latest Market Talks covering the Health Care sector. [ad_2] Source link
Biotech Stocks Join AI-Fueled Rally
[ad_1] Shares of Recursion Pharmaceuticals, Schrodinger and others that are implementing AI are surging. [ad_2] Source link
Novartis Raises 2023 Guidance; Launches $15 Bln Buyback
[ad_1] Novartis said it expected core operating income to grow in the low double digits from a previous expectation of…
ViewRay Files for Bankruptcy, Plans to Pursue Sale
[ad_1] ViewRay, which makes the MRIdian radiation-therapy system, said it has filed for bankruptcy and plans to sell some or…
Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
[ad_1] Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year…
Investor Group Takes Aim at Antibiotics, Demanding Changes From Fast-Food Companies
[ad_1] Concern over the rise of drug-resistant superbugs is spreading beyond hospital wards and health clinics to the world’s major…
WSJ News Exclusive | Bausch + Lomb’s CEO Inks First Big Deal Since Return
[ad_1] Eye-care company has agreed to pay $1.75 billion for Novartis’s dry-eye treatment Xiidra. [ad_2] Source link
GSK Reaches Confidential Settlement Over Zantac Litigation
[ad_1] GSK said it reached a confidential settlement with plaintiff James Goetz regarding the legal action concerning Zantac and accusations…